Home Sweden Living World Business Sports Entertain

EMA

Hair loss medications suspected to increase suicidal thoughts

The European Medicines Agency (EMA) has initiated an investigation into two medicines that are used, among other things, to treat hair loss, reports the Medical Products Agency in a [press release](https://www. lakemedelsverket.

Hair loss medications suspected to increase suicidal thoughts

The UK Approves Alzheimer's Medication

Despite a no in July from the European Medicines Agency EMA, the drug Leqembi is now approved for treatment of Alzheimer's patients in the United Kingdom. .

The UK Approves Alzheimer's Medication

Medicine Stop a Hard Blow for Alzheimer's Patients

The disappointment is great since a new drug against Alzheimer's has been rejected by the EU's pharmaceutical authority. It is outrageous, says Liselotte Jansson at the Alzheimer's Foundation.

Medicine Stop a Hard Blow for Alzheimer's Patients

Upwards on Wall Street – major companies recovered

The trading week on Wall Street ended in major, after many large technology companies had a shaky week. .

Upwards on Wall Street – major companies recovered

Alzheimer's drug rejected by EMA

The Alzheimer's drug lecanemab has not been approved by the European Medicines Agency EMA. The benefits are not considered to outweigh the potential drawbacks.

Alzheimer's drug rejected by EMA

More approve Alzheimer's medication

Israel, and just the other day Hong Kong, has now approved the Alzheimer's drug Leqembi for use, which the USA, Japan, South Korea, and China have done previously. This is stated by the Swedish pharmaceutical company Bioarctic in a press release.

More approve Alzheimer's medication